154 related articles for article (PubMed ID: 22324723)
1. Antineoplastic agents. 548. Synthesis of iodo- and diiodocombstatin phosphate prodrugs.
Pettit GR; Rosenberg HJ; Dixon R; Knight JC; Hamel E; Chapuis JC; Pettit RK; Hogan F; Sumner B; Ain KB; Trickey-Platt B
J Nat Prod; 2012 Mar; 75(3):385-93. PubMed ID: 22324723
[TBL] [Abstract][Full Text] [Related]
2. Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
Pettit GR; Grealish MP; Jung MK; Hamel E; Pettit RK; Chapuis JC; Schmidt JM
J Med Chem; 2002 Jun; 45(12):2534-42. PubMed ID: 12036362
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
Pettit GR; Thornhill A; Melody N; Knight JC
J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
Pettit GR; Melody N; Thornhill A; Knight JC; Groy TL; Herald CL
J Nat Prod; 2009 Sep; 72(9):1637-42. PubMed ID: 19719153
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic agents. 509: synthesis of fluorcombstatin phosphate and related 3-halostilbenes(1).
Pettit GR; Minardi MD; Rosenberg HJ; Hamel E; Bibby MC; Martin SW; Jung MK; Pettit RK; Cuthbertson TJ; Chapuis JC
J Nat Prod; 2005 Oct; 68(10):1450-8. PubMed ID: 16252907
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
Pettit GR; Lippert JW
Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
[TBL] [Abstract][Full Text] [Related]
9. Symmetrical Diamidates as a Class of Phosphate Prodrugs to Deliver the 5'-Monophosphate Forms of Anticancer Nucleoside Analogues.
Slusarczyk M; Ferrari V; Serpi M; Gönczy B; Balzarini J; McGuigan C
ChemMedChem; 2018 Nov; 13(21):2305-2316. PubMed ID: 30199147
[TBL] [Abstract][Full Text] [Related]
10. The investigation and bioorthogonal anticancer activity enhancement of a triphenylphosphine-labile prodrug of seleno-combretastatin-4.
Hou L; Huang W; Cheng J; Deng X; Lai H; Chen Z; Zhan Z; Feng P; Li Y; Yang F; Chen T
Chem Commun (Camb); 2020 Nov; 56(92):14495-14498. PubMed ID: 33150881
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic agents 322. synthesis of combretastatin A-4 prodrugs.
Pettit GR; Temple C; Narayanan VL; Varma R; Simpson MJ; Boyd MR; Rener GA; Bansal N
Anticancer Drug Des; 1995 Jun; 10(4):299-309. PubMed ID: 7786396
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug.
Liu W; Liang L; Zhao L; Tan H; Wu J; Qin Q; Gou X; Sun X
Bioorg Med Chem Lett; 2019 Feb; 29(3):487-490. PubMed ID: 30553736
[TBL] [Abstract][Full Text] [Related]
13. Antineoplastic agents. 552. Oxidation of combretastatin A-1: trapping the o-quinone intermediate considered the metabolic product of the corresponding phosphate prodrug.
Pettit GR; Thornhill AJ; Moser BR; Hogan F
J Nat Prod; 2008 Sep; 71(9):1561-3. PubMed ID: 18729517
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer.
Zhao RY; Erickson HK; Leece BA; Reid EE; Goldmacher VS; Lambert JM; Chari RV
J Med Chem; 2012 Jan; 55(2):766-82. PubMed ID: 22148292
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic agents 393. Synthesis of the trans-isomer of combretastatin A-4 prodrug.
Pettit GR; Rhodes MR; Herald DL; Chaplin DJ; Stratford MR; Hamel E; Pettit RK; Chapuis JC; Oliva D
Anticancer Drug Des; 1998 Dec; 13(8):981-93. PubMed ID: 10335271
[TBL] [Abstract][Full Text] [Related]
16. Potent double prodrug forms of synthetic phosphoantigens.
Harmon NM; Huang X; Schladetsch MA; Hsiao CC; Wiemer AJ; Wiemer DF
Bioorg Med Chem; 2020 Oct; 28(19):115666. PubMed ID: 32912439
[TBL] [Abstract][Full Text] [Related]
17. L-Aspartic and l-glutamic acid ester-based ProTides of anticancer nucleosides: Synthesis and antitumoral evaluation.
Gao LJ; De Jonghe S; Daelemans D; Herdewijn P
Bioorg Med Chem Lett; 2016 May; 26(9):2142-6. PubMed ID: 27032331
[TBL] [Abstract][Full Text] [Related]
18. Combretastatin dinitrogen-substituted stilbene analogues as tubulin-binding and vascular-disrupting agents.
Siles R; Ackley JF; Hadimani MB; Hall JJ; Mugabe BE; Guddneppanavar R; Monk KA; Chapuis JC; Pettit GR; Chaplin DJ; Edvardsen K; Trawick ML; Garner CM; Pinney KG
J Nat Prod; 2008 Mar; 71(3):313-20. PubMed ID: 18303849
[TBL] [Abstract][Full Text] [Related]
19. Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer.
Tokay E; Güngör T; Hacıoğlu N; Önder FC; Gülhan ÜG; Tok TT; Çelik A; Ay M; Köçkar F
Eur J Med Chem; 2020 Feb; 187():111937. PubMed ID: 31841727
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugs.
Pettit GR; Moser BR; Boyd MR; Schmidt JM; Pettit RK; Chapuis JC
Anticancer Drug Des; 2001; 16(4-5):185-93. PubMed ID: 12049477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
